Royal Philips NV (PHG) plans to buy medical-imaging company Volcano Corp. (VOL) for $1.2 billion, in one of Philips’ largest acquisitions in years, according to a Bloomberg report. The purchase of San Diego–based Volcano will ...
AtheroMed has obtained marketing approval from the US Food and Drug Administration (FDA) for its Phoenix atherectomy system for treating peripheral artery disease (PAD). Phoenix atherectomy system is a peripheral atherectomy catheter ...
Tags: FDA, pPAD, debulked material, Archimedes Screw
Older women with heart disease might be at increased risk for dementia, according to a new study. Researchers followed nearly 6,500 U.S. women, aged 65 to 79, who had healthy brain function when the study started. Those with heart disease ...
Tags: older women health, heart disease, dementia
Intact Vascular, a developer of medical devices for minimally invasive peripheral vascular procedures, has announced the start of enrollment in the Tack Optimized Balloon Angioplasty Below the Knee (TOBA-BTK) study. This multi-center ...
Tags: Intact Vascular, medical devices
US-based AngioScore has presented six-month clinical and quantitative coronary angiography results from the first-in-human (FIH) clinical trial of its drug-coated AngioSculpt PTCA scoring balloon catheter at the Transcatheter Cardiovascular ...
Tags: AngioScore, Balloon Catheter
The Israeli Ministry of Health (IMH) has approved Pluristem Therapeutics’ request to start a Phase II trial using its PLacental eXpanded (PLX) cells in the treatment of intermittent claudication (IC). IC is a subset of peripheral ...
Tags: clinical study, Medicine
Avinger, a manufacturer of multifunctional catheters, has received CE Mark approval for Pantheris, a lumectomy catheter designed to remove the blockage while avoiding the disruption of normal arterial wall structures. This lumivascular ...
Abbott has completed its acquisition of Idev Technologies, a privately held firm that manufactures next-generation medical devices for use by interventional radiologists, vascular surgeons and cardiologists, for $310m. Abbott believes ...
Tags: Abbott, Idev Technologies
Medtronic has submitted its first pre-market approval (PMA) module to the U.S. Food and Drug Administration (FDA) for the IN.PACT Admiral drug-eluting balloon designed to treat atherosclerotic lesions in the superficial femoral artery ...
Tags: Medtronic, Admiral Drug-Eluting
US-based Abbott has agreed to buy a stent maker and an eye surgery systems manufacturer in two separate deals, worth about $710m, as part of its strategy to expand its medical device business. Illinois-based Abbott agreed to purchase ...
Tags: Stent Maker, Ophthalmic Device
AngioScore, a US based endovascular company, has launched new 100 mm length AngioSculpt PTA Scoring Balloon Catheters to treat complex lesions in patients with peripheral artery disease (PAD) below the knee (BTK) including critical limb ...
Tags: AngioScore, PTA Scoring Balloon Catheters, peripheral artery disease, PAD
Medtronic has completed patient enrollment in controlled, multicenter, prospective IN.PACT SFA II clinical trial of its IN.PACT Admiral drug-eluting balloon device for treating patients with peripheral artery disease in the superficial ...
Tags: drug, Medtronic, eluting balloon study
Covidien has reported final 12-month results from Determination of Effectiveness of SilverHawk / TurboHawk Peripheral Plaque Excision Systems for the Treatment of Infrainguinal Vessels/Lower Extremities (DEFINITIVE LE ) trial. The ...
Tags: Covidien, 12-month results, DEFINITIVE LE trial, prospective study
Abbott has obtained the US Food and Drug Administration (FDA) approval for its Omnilink Elite Vascular Balloon-Expandable Stent system, designed as a treatment for atherosclerotic iliac artery lesions with reference vessel diameters of ≥ ...
Tags: Abbott, FDA, approval, Omnilink Elite stent, study, Omnilink Elite
Avinger has reported that it will present the CONNECT II clinical trial results at the Vascular Interventional Advances (VIVA) conference being held in Las Vegas, Nevada, US, between 9-12 October 2012. The prospective, multi-center, ...